All versions of MPEP now available on USPTO website

The USPTO has now made available all prior editions of the Manual of Patent Examining Procedure on its website here. This is great news for those who have ever had to try to track down a version of the MPEP that was more than about 10 years old, as they had not previously been easily […]

Continue Reading →

Reply briefs filed in claim and continuation rules case; administration opposes patent reform

Late Friday, the parties filed their reply briefs in the cases challenging the USPTO's claim and continuation rules. As with the parties' opposition filings, these briefs largely represent another repetition of the arguments raised in the parties motions for summary judgment. The motions have now been fully briefed, and the hearing on the parties' motions […]

Continue Reading →

Patent Reform Act of 2007 scheduled for consideration this month

The Patent Reform Act of 2007 (S. 1145) is now officially back on the radar. It was recently placed on the Senate's calendar, and is likely to be considered by the full Senate sometime this month. This has resulted in a corresponding increase in the lobbying efforts by those on both sides of the debate. […]

Continue Reading →

USPTO to start enforcing requirement that inventor oaths include reference to duty of disclosure

In a notice dated yesterday, the USPTO announced that it will begin enforcing compliance with 37 C.F.R. § 1.63(b)(3), which requires that inventor oaths include an acknowledgement of the duty to disclose information material to patentability under 37 C.F.R. § 1.56. Oaths filed on or after June 1, 2008 will have to have the language […]

Continue Reading →

Oppositions to motions for summary judgment filed in cases challenging claim and continuation rules

Yesterday, the USPTO, Glaxo, and Dr. Tafas filed their oppositions to the motions for summary judgment in the consolidated cases challenging the USPTO's claim and continuation rules. At first glance, they make many of the same arguments raised in the parties' motions for summary judgment. Interestingly, however, the USPTO has also moved to strike portions […]

Continue Reading →

Roundup of media coverage of oral arguments in Quanta v. LG

After the Supreme Court heard oral argument last week in Quanta Computer, Inc. v. LG Electronics, Inc. (No. 06-937), the media and blogosphere have begun to weigh in on the arguments. You can find our take on the arguments in this post, or click below for a sampling of the coverage from other sources. A […]

Continue Reading →

Oral argument in Quanta v. LG – some highlights

On Wednesday, the Supreme Court heard oral argument in Quanta Computer, Inc. v. LG Electronics, Inc. (No. 06-937), a case regarding the scope of the concept of patent exhaustion, also known as the first sale doctrine. While the entirety of the arguments is worth a read (the transcript is available here), click below for our […]

Continue Reading →

Timely article in Popular Science regarding the USPTO and its backlog

The passage below is from an article in Popular Science, and is timely given the current workload of the USPTO and statements by Director Dudas that application pendency will continue to increase: The Patent Office Has Become A National Disgrace THE Patent Office, in Washington, D. C, recently sent to a workman in a chemical […]

Continue Reading →

Patent Reform Act of 2007 to be passed in 2008?

The internet is abuzz with talk that the much-maligned Patent Reform Act of 2007 (H.R. 1908 & S. 1145) may be passed in some form this month. A draft version of the Senate Judiciary Committee's report on the bill was released earlier this week, and while it does not contain any revised provisions, it does […]

Continue Reading →

Tomorrow at the Supreme Court: Oral argument in Quanta v. LG

Tomorrow the Supreme Court will hear oral argument in Quanta Computer, Inc. v. LG Electronics, Inc. (No. 06-937). The case will determine whether patent owners who sell products embodying their patents conditionally are able to recover damages for patent infringement if the products are subsequently sold beyond the scope permitted by the original sale. The […]

Continue Reading →

Stay in Touch

Receive the latest news and updates from us and our attorneys.

Sign Up